Validation of Prognostic and Predictive Models for Therapeutic Response in Patients Treated with [177Lu]Lu-PSMA-617 Versus Cabazitaxel for Metastatic Castration-resistant Prostate Cancer (TheraP): A Post Hoc Analysis from a Randomised, Open-label, Phase 2 Trial
Titel:
Validation of Prognostic and Predictive Models for Therapeutic Response in Patients Treated with [177Lu]Lu-PSMA-617 Versus Cabazitaxel for Metastatic Castration-resistant Prostate Cancer (TheraP): A Post Hoc Analysis from a Randomised, Open-label, Phase 2 Trial
Auteur:
Gafita, Andrei Martin, Andrew J. Emmett, Louise Eiber, Matthias Iravani, Amir Fendler, Wolfgang P. Buteau, James Sandhu, Shahneen Azad, Arun A. Herrmann, Ken Stockler, Martin R. Davis, Ian D. Hofman, Michael S.